These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2847206)

  • 1. Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.
    Schneider LS; Severson JA; Chui HC; Pollock VE; Sloane RB; Fredrickson ER
    Psychiatry Res; 1988 Sep; 25(3):311-22. PubMed ID: 2847206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
    Hannah P; Adams D; Glover V; Sandler M
    J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet [3H]-imipramine binding is not modified in Alzheimer's disease.
    Galzin AM; Davous P; Roudier M; Lamour Y; Poirier MF; Langer SZ
    Psychiatry Res; 1989 Jun; 28(3):289-94. PubMed ID: 2548223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet imipramine binding in endogenous depressed patients and controls: relationship to platelet MAO and 5HT uptake during successful imipramine treatment.
    Quintana J
    Psychiatry Res; 1990 Sep; 33(3):229-42. PubMed ID: 2173840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease.
    Bonuccelli U; Piccini P; Marazziti D; Cassano GB; Muratorio A
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):139-47. PubMed ID: 2222781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased platelet 3H-imipramine binding in primary major depression compared with depression secondary to medical illness in elderly outpatients.
    Schneider LS; Severson JA; Sloane RB; Fredrickson ER
    J Affect Disord; 1988; 15(2):195-200. PubMed ID: 2851620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia.
    Suranyi-Cadotte BE; Gauthier S; Lafaille F; DeFlores S; Dam TV; Nair NP; Quirion R
    Life Sci; 1985 Dec; 37(24):2305-11. PubMed ID: 2999549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression.
    Nemeroff CB; Knight DL; Krishnan RR; Slotkin TA; Bissette G; Melville ML; Blazer DG
    Arch Gen Psychiatry; 1988 Oct; 45(10):919-23. PubMed ID: 2844132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased platelet 3H-imipramine binding in Down's syndrome.
    Tang SW; Berg JM; Bruni J; Davis A
    Psychiatry Res; 1988 Apr; 24(1):67-70. PubMed ID: 2839861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet tritiated imipramine binding in patients suffering from mania.
    Ellis PM; Mellsop GW; Beeston R; Cooke RR
    J Affect Disord; 1991 Jul; 22(3):105-10. PubMed ID: 1655851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet serotonergic markers and aggressive behaviour in healthy subjects.
    Castrogiovanni P; Capone MR; Maremmani I; Marazziti D
    Neuropsychobiology; 1994; 29(3):105-7. PubMed ID: 8022528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonin uptake and 3H-imipramine binding in panic disorder.
    Norman TR; Sartor DM; Judd FK; Burrows GD; Gregory MS; McIntyre IM
    J Affect Disord; 1989; 17(1):77-81. PubMed ID: 2544638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood platelets in psychopharmacological research.
    Rotman A
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):135-51. PubMed ID: 6310688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.
    Takeda T; Harada T; Otsuki S
    Biol Psychiatry; 1989 May; 26(1):52-60. PubMed ID: 2541808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
    Black DW; Kelly M; Myers C; Noyes R
    Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.